
Company valuation, historical trends, and peer comparisons.
According to Biostax Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.12M. This represents a change of -80.07% compared to the average of 5.60M of the last 4 quarters.
The mean historical Enterprise Value of Biostax Corp. over the last ten years is 9.10M. The current 1.12M Enterprise Value has changed -87.74% with respect to the historical average. Over the past ten years (40 quarters), BTAX's Enterprise Value was at its highest in in the March 2024 quarter at 6.09M. The Enterprise Value was at its lowest in in the September 2024 quarter at 5.35M.
Average
9.10M
Median
5.61M
Minimum
2.84M
Maximum
22.32M
Discovering the peaks and valleys of Biostax Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 455.23%
Maximum Annual Enterprise Value = 22.32M
Minimum Annual Increase = -67.75%
Minimum Annual Enterprise Value = 2.84M
| Year | Enterprise Value | Change |
|---|---|---|
| 2023 | 7.20M | -67.75% |
| 2022 | 22.32M | 455.23% |
| 2021 | 4.02M | 41.47% |
The current Enterprise Value of Biostax Corp. (BTAX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
11.18M
5-year avg
9.10M
10-year avg
9.10M
Biostax Corp.’s Enterprise Value is less than ADMA Biologics, Inc. (2.59B), less than Actinium Pharmaceuticals, Inc. (10.77M), less than Axsome Therapeutics, Inc. (6.80B), less than Bioxytran, Inc. (2.89M), greater than Cellectar Biosciences, Inc. (-20930838.00), less than Defence Therapeutics Inc. (23.71M), less than Estrella Immunopharma, Inc. (19.87M), greater than Nascent Biotech, Inc. (-215177.00), less than Oncotelic Therapeutics, Inc. (21.44M), less than Polaryx Therapeutics, Inc. Common Stock (76.69M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 2.59B | $2.52B | |
| 10.77M | $45.90M | |
| 6.80B | $6.90B | |
| 2.89M | $2.21M | |
| -20930838.00 | $11.53M | |
| 23.71M | $20.56M | |
| 19.87M | $20.02M | |
| -215177.00 | $34.44K | |
| 21.44M | $7.73M | |
| 76.69M | $88.23M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biostax Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Biostax Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Biostax Corp.'s Enterprise Value?
What is the highest Enterprise Value for Biostax Corp. (BTAX)?
What is the 3-year average Enterprise Value for Biostax Corp. (BTAX)?
What is the 5-year average Enterprise Value for Biostax Corp. (BTAX)?
How does the current Enterprise Value for Biostax Corp. (BTAX) compare to its historical average?